Adam Levy

2022 - Mineralys Therapeutics

In 2022, Adam Levy earned a total compensation of $1M as Chief Financial Officer and Secretary at Mineralys Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$190,900
Salary$334,926
Stock Awards$483,500
Other$7,262
Total$1,016,588

Levy received $483.5K in stock awards, accounting for 48% of the total pay in 2022.

Levy also received $190.9K in non-equity incentive plan, $334.9K in salary and $7.3K in other compensation.

Rankings

In 2022, Adam Levy's compensation ranked 2,999th out of 5,760 executives tracked by ExecPay. In other words, Levy earned more than 47.9% of executives.

ClassificationRankingPercentile
All
2,999
out of 5,760
48th
Division
Manufacturing
1,681
out of 3,136
46th
Major group
Chemicals And Allied Products
786
out of 1,422
45th
Industry group
Drugs
733
out of 1,323
45th
Industry
Pharmaceutical Preparations
530
out of 969
45th
Source: SEC filing on April 9, 2024.

Levy's colleagues

We found two more compensation records of executives who worked with Adam Levy at Mineralys Therapeutics in 2022.

2022

Jon Congleton

Mineralys Therapeutics

Chief Executive Officer

2022

David Rodman

Mineralys Therapeutics

Chief Medical Officer

News

You may also like